Octreotide Acetate API Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report aims to provide a comprehensive presentation of the global market for Octreotide Acetate API study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Octreotide Acetate API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Octreotide Acetate API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Octreotide Acetate API companies in 2021 (%)
The global Octreotide Acetate API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity Above 95% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Octreotide Acetate API include Hemmo Pharmaceuticals, Fresenius Kabi iPSUM, Bachem, PolyPeptide Laboratories AB, Chemical & Biopharmaceutical Labs of Patra S.A., Auro Peptides, Sun Pharmaceutical Industries, Mylan Laboratories and Ambiopharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Octreotide Acetate API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Octreotide Acetate API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Octreotide Acetate API Market Segment Percentages, by Type, 2021 (%)
Purity Above 95%
Purity Below 95%
Global Octreotide Acetate API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Octreotide Acetate API Market Segment Percentages, by Application, 2021 (%)
Injection
Others
Global Octreotide Acetate API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Octreotide Acetate API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Octreotide Acetate API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Octreotide Acetate API revenues share in global market, 2021 (%)
Key companies Octreotide Acetate API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Octreotide Acetate API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hemmo Pharmaceuticals
Fresenius Kabi iPSUM
Bachem
PolyPeptide Laboratories AB
Chemical & Biopharmaceutical Labs of Patra S.A.
Auro Peptides
Sun Pharmaceutical Industries
Mylan Laboratories
Ambiopharm
USV Private Limited
Chemi SPA
BCN Peptides
Teva Pharmaceutical Industries
ScinoPharm Taiwan
ALP Pharm Beijing
Hainan Shuangcheng Pharmaceuticals
Sinopep-Allsino BioPharmaceutical
Chengdu Shengnuo Biopharm
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Octreotide Acetate API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Octreotide Acetate API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Octreotide Acetate API Overall Market Size
2.1 Global Octreotide Acetate API Market Size: 2021 VS 2028
2.2 Global Octreotide Acetate API Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Octreotide Acetate API Sales: 2017-2028
3 Company Landscape
3.1 Top Octreotide Acetate API Players in Global Market
3.2 Top Global Octreotide Acetate API Companies Ranked by Revenue
3.3 Global Octreotide Acetate API Revenue by Companies
3.4 Global Octreotide Acetate API Sales by Companies
3.5 Global Octreotide Acetate API Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Octreotide Acetate API Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Octreotide Acetate API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Octreotide Acetate API Players in Global Market
3.8.1 List of Global Tier 1 Octreotide Acetate API Companies
3.8.2 List of Global Tier 2 and Tier 3 Octreotide Acetate API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Octreotide Acetate API Market Size Markets, 2021 & 2028
4.1.2 Purity Above 95%
4.1.3 Purity Below 95%
4.2 By Type - Global Octreotide Acetate API Revenue & Forecasts
4.2.1 By Type - Global Octreotide Acetate API Revenue, 2017-2022
4.2.2 By Type - Global Octreotide Acetate API Revenue, 2023-2028
4.2.3 By Type - Global Octreotide Acetate API Revenue Market Share, 2017-2028
4.3 By Type - Global Octreotide Acetate API Sales & Forecasts
4.3.1 By Type - Global Octreotide Acetate API Sales, 2017-2022
4.3.2 By Type - Global Octreotide Acetate API Sales, 2023-2028
4.3.3 By Type - Global Octreotide Acetate API Sales Market Share, 2017-2028
4.4 By Type - Global Octreotide Acetate API Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Octreotide Acetate API Market Size, 2021 & 2028
5.1.2 Injection
5.1.3 Others
5.2 By Application - Global Octreotide Acetate API Revenue & Forecasts
5.2.1 By Application - Global Octreotide Acetate API Revenue, 2017-2022
5.2.2 By Application - Global Octreotide Acetate API Revenue, 2023-2028
5.2.3 By Application - Global Octreotide Acetate API Revenue Market Share, 2017-2028
5.3 By Application - Global Octreotide Acetate API Sales & Forecasts
5.3.1 By Application - Global Octreotide Acetate API Sales, 2017-2022
5.3.2 By Application - Global Octreotide Acetate API Sales, 2023-2028
5.3.3 By Application - Global Octreotide Acetate API Sales Market Share, 2017-2028
5.4 By Application - Global Octreotide Acetate API Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Octreotide Acetate API Market Size, 2021 & 2028
6.2 By Region - Global Octreotide Acetate API Revenue & Forecasts
6.2.1 By Region - Global Octreotide Acetate API Revenue, 2017-2022
6.2.2 By Region - Global Octreotide Acetate API Revenue, 2023-2028
6.2.3 By Region - Global Octreotide Acetate API Revenue Market Share, 2017-2028
6.3 By Region - Global Octreotide Acetate API Sales & Forecasts
6.3.1 By Region - Global Octreotide Acetate API Sales, 2017-2022
6.3.2 By Region - Global Octreotide Acetate API Sales, 2023-2028
6.3.3 By Region - Global Octreotide Acetate API Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Octreotide Acetate API Revenue, 2017-2028
6.4.2 By Country - North America Octreotide Acetate API Sales, 2017-2028
6.4.3 US Octreotide Acetate API Market Size, 2017-2028
6.4.4 Canada Octreotide Acetate API Market Size, 2017-2028
6.4.5 Mexico Octreotide Acetate API Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Octreotide Acetate API Revenue, 2017-2028
6.5.2 By Country - Europe Octreotide Acetate API Sales, 2017-2028
6.5.3 Germany Octreotide Acetate API Market Size, 2017-2028
6.5.4 France Octreotide Acetate API Market Size, 2017-2028
6.5.5 U.K. Octreotide Acetate API Market Size, 2017-2028
6.5.6 Italy Octreotide Acetate API Market Size, 2017-2028
6.5.7 Russia Octreotide Acetate API Market Size, 2017-2028
6.5.8 Nordic Countries Octreotide Acetate API Market Size, 2017-2028
6.5.9 Benelux Octreotide Acetate API Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Octreotide Acetate API Revenue, 2017-2028
6.6.2 By Region - Asia Octreotide Acetate API Sales, 2017-2028
6.6.3 China Octreotide Acetate API Market Size, 2017-2028
6.6.4 Japan Octreotide Acetate API Market Size, 2017-2028
6.6.5 South Korea Octreotide Acetate API Market Size, 2017-2028
6.6.6 Southeast Asia Octreotide Acetate API Market Size, 2017-2028
6.6.7 India Octreotide Acetate API Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Octreotide Acetate API Revenue, 2017-2028
6.7.2 By Country - South America Octreotide Acetate API Sales, 2017-2028
6.7.3 Brazil Octreotide Acetate API Market Size, 2017-2028
6.7.4 Argentina Octreotide Acetate API Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Octreotide Acetate API Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Octreotide Acetate API Sales, 2017-2028
6.8.3 Turkey Octreotide Acetate API Market Size, 2017-2028
6.8.4 Israel Octreotide Acetate API Market Size, 2017-2028
6.8.5 Saudi Arabia Octreotide Acetate API Market Size, 2017-2028
6.8.6 UAE Octreotide Acetate API Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Hemmo Pharmaceuticals
7.1.1 Hemmo Pharmaceuticals Corporate Summary
7.1.2 Hemmo Pharmaceuticals Business Overview
7.1.3 Hemmo Pharmaceuticals Octreotide Acetate API Major Product Offerings
7.1.4 Hemmo Pharmaceuticals Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.1.5 Hemmo Pharmaceuticals Key News
7.2 Fresenius Kabi iPSUM
7.2.1 Fresenius Kabi iPSUM Corporate Summary
7.2.2 Fresenius Kabi iPSUM Business Overview
7.2.3 Fresenius Kabi iPSUM Octreotide Acetate API Major Product Offerings
7.2.4 Fresenius Kabi iPSUM Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.2.5 Fresenius Kabi iPSUM Key News
7.3 Bachem
7.3.1 Bachem Corporate Summary
7.3.2 Bachem Business Overview
7.3.3 Bachem Octreotide Acetate API Major Product Offerings
7.3.4 Bachem Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.3.5 Bachem Key News
7.4 PolyPeptide Laboratories AB
7.4.1 PolyPeptide Laboratories AB Corporate Summary
7.4.2 PolyPeptide Laboratories AB Business Overview
7.4.3 PolyPeptide Laboratories AB Octreotide Acetate API Major Product Offerings
7.4.4 PolyPeptide Laboratories AB Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.4.5 PolyPeptide Laboratories AB Key News
7.5 Chemical & Biopharmaceutical Labs of Patra S.A.
7.5.1 Chemical & Biopharmaceutical Labs of Patra S.A. Corporate Summary
7.5.2 Chemical & Biopharmaceutical Labs of Patra S.A. Business Overview
7.5.3 Chemical & Biopharmaceutical Labs of Patra S.A. Octreotide Acetate API Major Product Offerings
7.5.4 Chemical & Biopharmaceutical Labs of Patra S.A. Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.5.5 Chemical & Biopharmaceutical Labs of Patra S.A. Key News
7.6 Auro Peptides
7.6.1 Auro Peptides Corporate Summary
7.6.2 Auro Peptides Business Overview
7.6.3 Auro Peptides Octreotide Acetate API Major Product Offerings
7.6.4 Auro Peptides Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.6.5 Auro Peptides Key News
7.7 Sun Pharmaceutical Industries
7.7.1 Sun Pharmaceutical Industries Corporate Summary
7.7.2 Sun Pharmaceutical Industries Business Overview
7.7.3 Sun Pharmaceutical Industries Octreotide Acetate API Major Product Offerings
7.7.4 Sun Pharmaceutical Industries Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.7.5 Sun Pharmaceutical Industries Key News
7.8 Mylan Laboratories
7.8.1 Mylan Laboratories Corporate Summary
7.8.2 Mylan Laboratories Business Overview
7.8.3 Mylan Laboratories Octreotide Acetate API Major Product Offerings
7.8.4 Mylan Laboratories Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.8.5 Mylan Laboratories Key News
7.9 Ambiopharm
7.9.1 Ambiopharm Corporate Summary
7.9.2 Ambiopharm Business Overview
7.9.3 Ambiopharm Octreotide Acetate API Major Product Offerings
7.9.4 Ambiopharm Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.9.5 Ambiopharm Key News
7.10 USV Private Limited
7.10.1 USV Private Limited Corporate Summary
7.10.2 USV Private Limited Business Overview
7.10.3 USV Private Limited Octreotide Acetate API Major Product Offerings
7.10.4 USV Private Limited Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.10.5 USV Private Limited Key News
7.11 Chemi SPA
7.11.1 Chemi SPA Corporate Summary
7.11.2 Chemi SPA Octreotide Acetate API Business Overview
7.11.3 Chemi SPA Octreotide Acetate API Major Product Offerings
7.11.4 Chemi SPA Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.11.5 Chemi SPA Key News
7.12 BCN Peptides
7.12.1 BCN Peptides Corporate Summary
7.12.2 BCN Peptides Octreotide Acetate API Business Overview
7.12.3 BCN Peptides Octreotide Acetate API Major Product Offerings
7.12.4 BCN Peptides Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.12.5 BCN Peptides Key News
7.13 Teva Pharmaceutical Industries
7.13.1 Teva Pharmaceutical Industries Corporate Summary
7.13.2 Teva Pharmaceutical Industries Octreotide Acetate API Business Overview
7.13.3 Teva Pharmaceutical Industries Octreotide Acetate API Major Product Offerings
7.13.4 Teva Pharmaceutical Industries Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.13.5 Teva Pharmaceutical Industries Key News
7.14 ScinoPharm Taiwan
7.14.1 ScinoPharm Taiwan Corporate Summary
7.14.2 ScinoPharm Taiwan Business Overview
7.14.3 ScinoPharm Taiwan Octreotide Acetate API Major Product Offerings
7.14.4 ScinoPharm Taiwan Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.14.5 ScinoPharm Taiwan Key News
7.15 ALP Pharm Beijing
7.15.1 ALP Pharm Beijing Corporate Summary
7.15.2 ALP Pharm Beijing Business Overview
7.15.3 ALP Pharm Beijing Octreotide Acetate API Major Product Offerings
7.15.4 ALP Pharm Beijing Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.15.5 ALP Pharm Beijing Key News
7.16 Hainan Shuangcheng Pharmaceuticals
7.16.1 Hainan Shuangcheng Pharmaceuticals Corporate Summary
7.16.2 Hainan Shuangcheng Pharmaceuticals Business Overview
7.16.3 Hainan Shuangcheng Pharmaceuticals Octreotide Acetate API Major Product Offerings
7.16.4 Hainan Shuangcheng Pharmaceuticals Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.16.5 Hainan Shuangcheng Pharmaceuticals Key News
7.17 Sinopep-Allsino BioPharmaceutical
7.17.1 Sinopep-Allsino BioPharmaceutical Corporate Summary
7.17.2 Sinopep-Allsino BioPharmaceutical Business Overview
7.17.3 Sinopep-Allsino BioPharmaceutical Octreotide Acetate API Major Product Offerings
7.17.4 Sinopep-Allsino BioPharmaceutical Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.17.5 Sinopep-Allsino BioPharmaceutical Key News
7.18 Chengdu Shengnuo Biopharm
7.18.1 Chengdu Shengnuo Biopharm Corporate Summary
7.18.2 Chengdu Shengnuo Biopharm Business Overview
7.18.3 Chengdu Shengnuo Biopharm Octreotide Acetate API Major Product Offerings
7.18.4 Chengdu Shengnuo Biopharm Octreotide Acetate API Sales and Revenue in Global (2017-2022)
7.18.5 Chengdu Shengnuo Biopharm Key News
8 Global Octreotide Acetate API Production Capacity, Analysis
8.1 Global Octreotide Acetate API Production Capacity, 2017-2028
8.2 Octreotide Acetate API Production Capacity of Key Manufacturers in Global Market
8.3 Global Octreotide Acetate API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Octreotide Acetate API Supply Chain Analysis
10.1 Octreotide Acetate API Industry Value Chain
10.2 Octreotide Acetate API Upstream Market
10.3 Octreotide Acetate API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Octreotide Acetate API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Octreotide Acetate API Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|